Trials / Recruiting
RecruitingNCT07441733
Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients
INFLUENCE II - a Pilot Study for Implementation Identification of Sentinel Lymph Nodes in Breast Cancer Patients Through Non-invasively FLUorEsceNt Imaging Using indoCyaninE Green: a Pilot Study for Implementation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Casa di Cura Dott. Pederzoli · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This single-institution pilot study uses a pre- and post-implementation design to evaluate the implementation of ICG fluorescent imaging for sentinel lymph node biopsy (SLNB) in an Italian hospital.
Detailed description
Pre-implementation: standard sentinel node procedure using 99mTc-nanocolloid, which implies 99mTc injection the day or the morning before surgery. Transition period: participating surgeons will receive on-site training, proctoring, and ongoing guidance from experienced surgeons and early adopters of the ICG method from St. Antonius Hospital, Utrecht, The Netherlands until they achieve confidence and proficiency in using ICG for SLNB. Post-implementation: 5 mg (2 ml) ICG will be injected periareolar after administration of general anesthesia and before incision. The SLN will be visualized by fluorescent imaging using a fluorescence camera. Main study endpoints: Primary endpoint is the identification rate of SLNs achieved by 99mTc-nanocolloid or the fluorescent signal of ICG. Secondary endpoints are total number of LNs removed, detection time, total operative time, complications and (serious) adverse events, loco regional recurrence after 1 year follow-up, pre-implementation expectations regarding ICG, post-implementation experiences regarding ICG including barriers and success factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ICG used as a tracer for sentinel lymph node | ICG used as a tracer for sentinel lymph node instead of technetium 99 |
| PROCEDURE | technetium 99 used as a tracer for sentinel lymph node | technetium 99 used as a tracer for sentinel lymph node instead of ICG |
Timeline
- Start date
- 2024-11-07
- Primary completion
- 2025-03-31
- Completion
- 2026-03-01
- First posted
- 2026-03-02
- Last updated
- 2026-03-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07441733. Inclusion in this directory is not an endorsement.